溃疡性结肠炎缓解期的肠道黏膜低度炎性反应及其意义

被引：14

作者：

王承党 ^{[1
,2
]}

郭晓雄 ^{[1
,2
]}

机构：

[1] 福建医科大学附属第一医院消化内科

[2] 福建医科大学消化系疾病研究室

来源：

国际消化病杂志 | 2014年 / 34卷 / 01期

关键词：

D O I：

暂无

中图分类号：

R574.62 [结肠疾病];

学科分类号：

100201 [内科学];

摘要：

<正>溃疡性结肠炎(UC)是一种病因不明的慢性、非特异性肠道炎性反应,病变多累及直肠和乙状结肠的黏膜和黏膜下层,并可向全结肠蔓延,呈反复交替发作和缓解的特点,因此,治疗目的是诱导缓解和维持缓解,避免疾病活动和复发。在临床上,早期的治疗目标是以临床症状消失为标志的"临床缓解",近年来治疗目标提升为"黏膜愈合(mucosal healing)"。但即使黏膜愈合了,UC患者的肠道黏膜仍然存在持续的低度炎性反应,必须重视这种低

引用

页码：3 / 5

页数：3

共 10 条

[1]

Characterization of IBS-like symptoms in patients with ulcerative colitis in clinical remission [J].

Jonefjall, B. ;

Strid, H. ;

Ohman, L. ;

Svedlund, J. ;

Bergstedt, A. ;

Simren, M. .

NEUROGASTROENTEROLOGY AND MOTILITY, 2013, 25 (09) :756-E578

[2]

Majority of patients with inflammatory bowel disease in clinical remission have mucosal inflammation.[J].Judith E. Baars;Veerle J.A.A. Nuij;Bas Oldenburg;Ernst J. Kuipers;Christien J. van der Woude.Inflamm Bowel Dis.2011, 9

[3]

Mucosal Healing Predicts Late Outcomes After the First Course of Corticosteroids for Newly Diagnosed Ulcerative Colitis [J].

Ardizzone, Sandro ;

Cassinotti, Andrea ;

Duca, Piergiorgio ;

Mazzali, Cristina ;

Penati, Chiara ;

Manes, Gianpiero ;

Marmo, Riccardo ;

Massari, Alessandro ;

Molteni, Paola ;

Maconi, Giovanni ;

Porro, Gabriele Bianchi .

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2011, 9 (06) :483-U117

[4]

Mucosal healing for predicting clinical outcome in patients with ulcerative colitis using thiopurines in monotherapy [J].

Lopez-Palacios, Natalia ;

Mendoza, Juan L. ;

Taxonera, Carlos ;

Lana, Raquel ;

Esteban Lopez-Jamar, Jose Miguel ;

Diaz-Rubio, Manuel .

EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2011, 22 (06) :621-625

[5]

Early Mucosal Healing With Infliximab Is Associated With Improved Long-term Clinical Outcomes in Ulcerative Colitis [J].

Colombel, Jean Frederic ;

Rutgeerts, Paul ;

Reinisch, Walter ;

Esser, Dirk ;

Wang, Yanxin ;

Lang, Yinghua ;

Marano, Colleen W. ;

Strauss, Richard ;

Oddens, Bjoern J. ;

Feagan, Brian G. ;

Hanauer, Stephen B. ;

Lichtenstein, Gary R. ;

Present, Daniel ;

Sands, Bruce E. ;

Sandborn, William J. .

GASTROENTEROLOGY, 2011, 141 (04) :1194-1201

[6]

Clinical trial: controlled, open, randomized multicentre study comparing the effects of treatment on quality of life, safety and efficacy of budesonide or mesalazine enemas in active left-sided ulcerative colitis [J].

Hartmann, F. ;

Stein, J. .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2010, 32 (03) :368-376

[7]

83 Efficacy and Tolerability of a Once Daily Treatment with Budesonide Capsules Versus Mesalamine Granules for the Treatment of Active Ulcerative Colitis: A Randomized; Double-Blind; Double-Dummy; Multicenter Study.[J].Volker Gross;Ivan Bunganic;Tatyana L. Mikhailova;Limas Kupcinskas;Gediminas Kiudelis;Zsolt Tulassay;Libor Gabalec;Andrey Dorofeyev;Jelena Derova;Roland Greinwald;Ralph Mueller.Gastroenterology.2009, 5

[8]

Ulcerative colitis and irritable bowel syndrome: relationships with quality of life [J].

Ansari, Reza ;

Attari, Fatemeh ;

Razjouyan, Hadi ;

Etemadi, Arash ;

Amjadi, Hiva ;

Merat, Shahin ;

Malekzadeh, Reza .

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2008, 20 (01) :46-50

[9]

<ce:link locator="fx1"/> A Review of Activity Indices and Efficacy End Points for Clinical Trials of Medical Therapy in Adults With Ulcerative Colitis.[J]..Gastroenterology.2007, 2

[10]

<ce:link locator="fx1"/> Histologic Inflammation Is a Risk Factor for Progression to Colorectal Neoplasia in Ulcerative Colitis: A Cohort Study.[J].Roopali Bansal Gupta;Noam Harpaz;Steven Itzkowitz;Sabera Hossain;Sierra Matula;Asher Kornbluth;Carol Bodian;Thomas Ullman.Gastroenterology.2007, 4

← 1 →